Return to content in this issue

 

Efficacy of Benralizumab and Clinical Course of IgG4 in Eosinophilic Granulomatosis With Polyangiitis

Miyata Y, Inoue H, Homma T, Tanaka A, Sagara H

Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan

J Investig Allergol Clin Immunol 2021; Vol 31(4) : 346-348
doi: 10.18176/jiaci.0648

Key words: Eosinophilic granulomatosis with polyangiitis (EGPA), Benralizumab, Anti-IL-5 receptor antibody, IgG4, MPO-ANCA